Replimune Group Balance Sheet Health
Financial Health criteria checks 5/6
Replimune Group has a total shareholder equity of $421.5M and total debt of $44.4M, which brings its debt-to-equity ratio to 10.5%. Its total assets and total liabilities are $532.9M and $111.4M respectively.
Key information
10.5%
Debt to equity ratio
US$44.43m
Debt
Interest coverage ratio | n/a |
Cash | US$466.35m |
Equity | US$421.54m |
Total liabilities | US$111.39m |
Total assets | US$532.93m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7R8's short term assets ($479.2M) exceed its short term liabilities ($38.7M).
Long Term Liabilities: 7R8's short term assets ($479.2M) exceed its long term liabilities ($72.7M).
Debt to Equity History and Analysis
Debt Level: 7R8 has more cash than its total debt.
Reducing Debt: 7R8's debt to equity ratio has increased from 0% to 10.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 7R8 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 7R8 has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 32.4% each year.